Product Information

CALCIUM ACETATE 667 MG CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1669 per EA under NDC 00054008826. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Feb 26, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CALCIUM ACETATE 667 MG CAPSULE

Calcium Acetate
$0.1669per EA

Strength

667 mg/1

NDC

00054008826

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CALCIUM ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077728

FDA Approved

2/26/2008

TE Code

AB

On Market Since

2/26/2008

Pharmacological Classes

Blood Coagulation Factor
Calcium
Cations
Divalent
Increased Coagulation Factor Activity
Phosphate Binder
Phosphate Chelating Activity

Price Statistics

The NADAC for CALCIUM ACETATE 667 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 65.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1669 per EA
All-time high$0.6967 (Apr 16, 2014)
All-time low$0.1369 (Nov 20, 2024)
52-week high$0.2245
52-week low$0.1669
Median price$0.2423
Average price$0.2961
Largest weekly change+40.6% (Mar 19, 2014)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.0%

1M

-0.0%

3M

-3.6%

6M

-6.1%

1Y

-25.6%

3Y

-19.7%

5Y

-54.4%

All

-65.8%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CALCIUM ACETATE 667 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CALCIUM ACETATE 667 MG CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1669 per EA (NDC 00054008826), effective Aug 19, 2026.

How has the price of CALCIUM ACETATE 667 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CALCIUM ACETATE 667 MG CAPSULE has declined 65.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CALCIUM ACETATE 667 MG CAPSULE?

Since Nov 28, 2013, the NADAC for CALCIUM ACETATE 667 MG CAPSULE has ranged from a low of $0.1369 (Nov 20, 2024) to a high of $0.6967 (Apr 16, 2014), with a median of $0.2423 per EA.

Are there cheaper alternatives to CALCIUM ACETATE 667 MG CAPSULE?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CALCIUM ACETATE 667 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures CALCIUM ACETATE 667 MG CAPSULE?

CALCIUM ACETATE 667 MG CAPSULE (NDC 00054008826) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.